Double-Blind MethodTreatment OutcomeSingle-Blind MethodClinical ProtocolsResearch DesignPizotylineNeuropsychiatryPlacebosBronchodilator AgentsAdministration, InhalationSample SizePeak Expiratory Flow RateBeclomethasoneDrug Administration ScheduleEmollientsDrug Therapy, CombinationAlbuterolTime FactorsAsthmaAdministration, OralPlacebo EffectDrug CombinationsLice InfestationsPediculusAndrostadienesAnti-Asthmatic AgentsBudesonideRandomized Controlled Trials as TopicEthanolaminesAminosalicylic AcidsOndansetronForced Expiratory VolumeProspective StudiesTea Tree OilDose-Response Relationship, DrugAdministration, TopicalPregnenedionesScopolamine DerivativesPatient ComplianceCost-Benefit AnalysisHeartburnPain MeasurementAntihypertensive AgentsAnti-Inflammatory AgentsRanitidineMesalamineAnti-Inflammatory Agents, Non-SteroidalSeverity of Illness IndexNebulizers and VaporizersRandom AllocationAntiemeticsFollow-Up StudiesAnti-Ulcer AgentsAmlodipineQuality of LifeHeadacheAnalysis of VarianceBlood PressurePilot ProjectsSafetyArea Under CurveOutcome Assessment (Health Care)OmeprazoleGlucocorticoidsData Interpretation, StatisticalStatistics, NonparametricAtenololIntervention StudiesPrednisoloneDiabetes Mellitus, Type 2Clinical Trials as TopicQuinolinesAngiotensin-Converting Enzyme InhibitorsAdrenergic beta-AgonistsPhytotherapyCross-Over StudiesAnalgesicsTetrazolesRespiratory Function TestsPatient SatisfactionChronic DiseaseHypertensionPainCognitive TherapyQuestionnairesExercise TherapyPulmonary Disease, Chronic ObstructiveRecurrenceNetherlandsHemoglobin A, GlycosylatedAdrenergic beta-AntagonistsHeart RatePatient SelectionCalcium Channel BlockersGreat BritainInfusions, IntravenousPsychiatric Status Rating ScalesEnglandHeart FailureLung